Identification of a seven-gene prognostic model for renal cell carcinoma associated with CD8+T lymphocyte cell

Jingbang Liu,Tao Jiang
DOI: https://doi.org/10.1097/md.0000000000039938
IF: 1.6
2024-10-09
Medicine
Abstract:An estimated 14,890 individuals will die from renal cell carcinoma (RCC) and 81,800 new cases of RCC are anticipated in the United States by the end of 2023. [ 1 ] Although most epidemiological data are general for RCC, its histologically accounts for the vast majority (90%) of reported cases. [ 2 ] RCC originates from the renal tubular epithelial cells that line the proximal convoluted tubules and tiny kidney conduits that carry urine. [ 3 ] High blood pressure, obesity, and smoking increase the risk of RCC. [ 4 ] Approximately 50% of RCC cases are accidentally discovered upon medical checkups, with approximately 25% of patients diagnosed with metastatic disease. [ 5 ] The 5-year relative survival rates through surgical treatment and adjunctive therapy have shown some improvement; however, the overall prognosis remains poor, particularly for metastatic RCC. [ 6 ] Traditional treatment methods, such as surgery and chemotherapy, have shown unsatisfactory results. [ 6 ] In 2012, the International Society of Urological Pathology implemented a novel classification system for RCC, principally centered around the evaluation of nucleoli. This approach categorizes RCC into 4 distinct classes. [ 7 ]
medicine, general & internal
What problem does this paper attempt to address?